Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: An observational study

Transplantation Research

Volumn 2, Issue 1, 2013, Pages

  Heldal, Kristian ^a   Thorarinsdottir, Solveig ^a   Hartmann, Anders ^b,c   Leivestad, Torbjørn ^b   Reisæter, Anna V ^b   Foss, Aksel E ^b,c   Midtvedt, Karsten ^b  

^a TELEMARK HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Age; Expanded criteria donor; Induction treatment; Kidney transplantation; Rejection; Survival

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; FEMALE; GRAFT SURVIVAL; HUMAN; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PRIORITY JOURNAL; VERY ELDERLY;

EID: 84887965980     PISSN: None     EISSN: 20471440     Source Type: Journal    
DOI: 10.1186/2047-1440-2-11     Document Type: Article

References (30)

1. Jager KJ, van Dijk PC, Dekker FW, Stengel B, Simpson K, Briggs JD. The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes. Clin Nephrol 2003, 60:352-360.
2. Kurella M, Covinsky KE, Collins AJ, Chertow GM. Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 2007, 146:177-183.
3. Macrae J, Friedman AL, Friedman EA, Eggers P. Live and deceased donor kidney transplantation in patients aged 75 years and older in the United States. Int Urol Nephrol 2005, 37:641-648.
4. Port FK, Merion RM, Roys EC, Wolfe RA. Trends in organ donation and transplantation in the United States, 1997 to 2006. Am J Transplant 2008, 8:911-921.
5. Heldal K, Hartmann A, Grootendorst DC, de Jager DJ, Leivestad T, Foss A, Midtvedt K. Benefit of kidney transplantation beyond 70 years of age. Nephrol Dial Transplant 2010, 25:1680-1687.
6. Port FK, Bragg-Gresham JL, Metzger RA, Dykstra DM, Gillespie BW, Young EW, Delmonico FL, Wynn JJ, Merion RM, Wolfe RA, et al. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 2002, 74:1281-1286.
7. Webster AC, Ruster LP, McGee R, Matheson SL, Higgins GY, Willis NS, Chapman JR, Craig JC. Interleukin 2 receptor antagonists for kidney transplant recipients. Cochrane Database Syst Rev 2010, 1. CD003897.
8. Heldal K, Hartmann A, Leivestad T, Foss A, Midtvedt K. Risk variables associated with the outcome of kidney recipients >70 years of age in the new millennium. Nephrol Dial Transplant 2011, 26:2706-2711.
9. Treckmann J, Moers C, Smits JM, Gallinat A, Maathuis MH, van Kasterop-Kutz M, Jochmans I, van der Heide JJH, Squifflet JP, van Heurn E, et al. Machine perfusion versus cold storage for preservation of kidneys from expanded criteria donors after brain death. Transpl Int 2011, 24:548-554.
10. Frei U, Noeldeke J, Machold-Fabrizii V, Arbogast H, Margreiter R, Fricke L, Voiculescu A, Kliem V, Ebel H, Albert U, et al. Prospective age-matching in elderly kidney transplant recipients - a five-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008, 8:50-57.
11. Danovitch GM, Gill J, Bunnapradist S. Immunosuppression of the elderly kidney transplant recipient. Transplantation 2007, 84:285-291.
12. Heldal K, Leivestad T, Hartmann A, Svendsen MV, Lien BH, Midtvedt K. Kidney transplantation in the elderly - the Norwegian experience. Nephrol Dial Transplant 2008, 23:1026-1031.
13. Badowski M, Gurk-Turner C, Cangro C, Weir M, Philosophe B, Klassen D, Haririan A. The impact of reduced immunosuppression on graft outcomes in elderly renal transplant recipients. Clin Transplant 2009, 23:930-937.
14. de Fijter JW, Mallat MJ, Doxiadis II, Ringers J, Rosendaal FR, Claas FH, Paul LC. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am SocNephrol 2001, 12:1538-1546.
15. Pratschke J, Merk V, Reutzel-Selke A, Pascher A, Denecke C, Lun A, Said A, Schonemann C, Ulrich F, Reinke P, et al. Potent early immune response after kidney transplantation in patients of the European senior transplant program. Transplantation 2009, 87:992-1000.
16. Oberhuber R, Ge X, Tullius SG. Donor age-specific injury and immune responses. Am J Transplant 2012, 12:38-42.
17. Ekberg H, Tedesco-Silva H, Demirbas A, Vitko S, Nashan B, Gurkan A, Margreiter R, Hugo C, Grinyo JM, Frei U, et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007, 357:2562-2575.
18. Heldal K, Hartmann A, Leivestad T, Svendsen MV, Foss A, Lien B, Midtvedt K. Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity. Transplantation 2009, 87:1045-1051.
19. Foss A, Heldal K, Scott H, Foss S, Leivestad T, Jorgensen PF, Scholz T, Midtvedt K. Kidneys from deceased donors more than 75 years perform acceptably after transplantation. Transplantation 2009, 87:1437-1441.
20. Fraser SM, Rajasundaram R, Aldouri A, Farid S, Morris-Stiff G, Baker R, Newstead CG, Toogood GJ, Menon KV, Ahmad N. Acceptable outcome after kidney transplantation using 'expanded criteria donor' grafts. Transplantation 2010, 89:88-96.
21. Rigotti P, Ekser B, Furian L, Baldan N, Valente ML, Boschiero L, Motterlini N, Perna A, Remuzzi G, Ruggenenti P. Outcome of renal transplantation from very old donors. N Engl J Med 2009, 360:1464-1465.
22. Patel SJ, Knight RJ, Suki WN, Abdellatif A, Duhart BT, Krauss AG, Mannan S, Nezakatgoo N, Osama GA. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 years of age. Clin Transplant 2011, 25:E250-E256.
23. Deeks ED, Keating GM. Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection. Drugs 2009, 69:1483-1512.
24. Jager KJ, Zoccali C, Macleod A, Dekker FW. Confounding: what it is and how to deal with it. Kidney Int 2008, 73:256-260.
25. de Fijter JW. An old virtue to improve senior programs. Transpl Int 2009, 22:259-268.
26. Jager KJ, Stel VS, Wanner C, Zoccali C, Dekker FW. The valuable contribution of observational studies to nephrology. Kidney Int 2007, 72:671-675.
27. Stel VS, Jager KJ, Zoccali C, Wanner C, Dekker FW. The randomized clinical trial: an unbeatable standard in clinical research?. Kidney Int 2007, 72:539-542.
28. Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med 2011, 26:783-790.
29. Meyer JM, Archdeacon P, Albrecht R. FDA perspective: enrollment of elderly transplant recipients in clinical trials. Transplantation 2013, 95:916-918.
30. Rao PS, Merion RM, Ashby VB, Port FK, Wolfe RA, Kayler LK. Renal transplantation in elderly patients older than 70 years of age: results from the scientific registry of transplant recipients. Transplantation 2007, 83:1069-1074.